Cyclacel Pharmaceuticals Inc (CYCC) — Net Asset Momentum
Cyclacel Pharmaceuticals Inc (CYCC) recorded a net asset momentum of -458.2% as of December 2024, with net assets of $-2.17 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Cyclacel Pharmaceuticals Inc book value and equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Cyclacel Pharmaceuticals Inc Net Asset Momentum (2000–2024)
This chart tracks Cyclacel Pharmaceuticals Inc's year-over-year net asset growth across 25 annual reporting periods from 2000 to 2024. The most recent momentum reading is -458.2%, with net assets of $-2.17 Million USD as of December 2024. For live market cap and overall valuation, see Cyclacel Pharmaceuticals Inc market cap and net worth.
Annual Net Asset History for Cyclacel Pharmaceuticals Inc (2000–2024)
The table below shows the complete annual net asset history for Cyclacel Pharmaceuticals Inc from 2000 to 2024, covering 25 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Cyclacel Pharmaceuticals Inc (CYCC) tangible net worth to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $-2.17 Million | $4.09 Million | $6.27 Million | ▼ -458.2% |
| 2023 | $607.00K | $8.80 Million | $8.20 Million | ▼ -97.0% |
| 2022 | $20.43 Million | $28.05 Million | $7.62 Million | ▼ -45.8% |
| 2021 | $37.69 Million | $43.14 Million | $5.44 Million | ▲ +13.3% |
| 2020 | $33.26 Million | $36.80 Million | $3.54 Million | ▲ +184.3% |
| 2019 | $11.70 Million | $15.31 Million | $3.61 Million | ▼ -23.4% |
| 2018 | $15.27 Million | $19.82 Million | $4.55 Million | ▼ -29.8% |
| 2017 | $21.77 Million | $26.00 Million | $4.24 Million | ▲ +52.5% |
| 2016 | $14.27 Million | $19.66 Million | $5.39 Million | ▼ -24.2% |
| 2015 | $18.84 Million | $24.76 Million | $5.93 Million | ▼ -13.2% |
| 2014 | $21.69 Million | $29.39 Million | $7.70 Million | ▼ -22.6% |
| 2013 | $28.02 Million | $35.52 Million | $7.50 Million | ▲ +179.7% |
| 2012 | $10.02 Million | $19.35 Million | $9.34 Million | ▼ -48.6% |
| 2011 | $19.50 Million | $26.00 Million | $6.50 Million | ▼ -21.8% |
| 2010 | $24.92 Million | $31.46 Million | $6.54 Million | ▲ +436.7% |
| 2009 | $4.64 Million | $14.47 Million | $9.82 Million | ▼ -77.5% |
| 2008 | $20.64 Million | $30.96 Million | $10.31 Million | ▼ -64.4% |
| 2007 | $57.97 Million | $75.91 Million | $17.94 Million | ▲ +7.5% |
| 2006 | $53.92 Million | $63.28 Million | $9.36 Million | ▲ +269.2% |
| 2005 | $14.60 Million | $21.45 Million | $6.84 Million | ▼ -66.9% |
| 2004 | $44.12 Million | $55.60 Million | $11.48 Million | ▲ +168.0% |
| 2003 | $-64.84 Million | $18.50 Million | $83.34 Million | ▼ -34.7% |
| 2002 | $-48.12 Million | $21.54 Million | $69.66 Million | ▼ -32.7% |
| 2001 | $-36.26 Million | $24.73 Million | $60.99 Million | ▼ -42.8% |
| 2000 | $-25.38 Million | $28.48 Million | $53.86 Million | — |